Reply to Kalil et al., “Is daptomycin plus ceftaroline associated with better clinical outcomes than standard of care monotherapy for staphylococcus aureus bacteremia?⇝

Authors

George Sakoulas, Sharp Memorial Hospital
Geriak, Sharp Memorial Hospital
Fadi Haddad, Sharp Grossmont Hospital
Warren Rose, University of Wisconsin-Madison
Kerry LaPlante, University of Rhode Island
Marcus Zervos, Henry Ford Hospital
Ravina Kullar, LLC
Victor Nizet, University of California, San Diego

Document Type

Letter to the Editor

Date of Original Version

1-1-2019

Publication Title, e.g., Journal

Antimicrobial Agents and Chemotherapy

Volume

63

Issue

11

Citation/Publisher Attribution

Sakoulas, George, Geriak, Fadi Haddad, Warren Rose, Kerry LaPlante, Marcus Zervos, Ravina Kullar, and Victor Nizet. "Reply to Kalil et al., “Is daptomycin plus ceftaroline associated with better clinical outcomes than standard of care monotherapy for staphylococcus aureus bacteremia?⇝." Antimicrobial Agents and Chemotherapy 63, 11 (2019). doi: 10.1128/AAC.01347-19.